OLFAX, LLC

ASHEVILLE, NC · Medtech · Private

A device for sphenopalatine ganglion (SPG) block procedures to treat migraine by targeting the trigeminal nerve

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
ASHEVILLE, NC
Latest Form D
$110K, Jun 2024
Total capital
$447K
Federal grants
$337K
1 award · 2022
Rank in peer group#122 of 477
Private capital raised
$110K
1 Form D · last Jun 2024
29 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2026
Rank in peer group#155 of 477

Capital timeline

202220232024FEDERAL ↑EQUITY ↓Cumulative $447K$337K1st Form D$110K
202220232024FEDERAL ↑EQUITY ↓Cumulative $447K$337K1st Form D$110K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$110K
  • Federal grantHealth and Human S · Phase I · Development of an intranasal, direct to nerve treatment for headache disorders$337K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

22months

from OLFAX, LLC’s first federal award to its first private round.

First federal award · Aug 2022
Health and Human S · $337K
First Form D · Jun 2024
$110K · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#122 · top 26%
  • Granted patents#155 · top 32%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Jason T CookResearcherExecutive OfficerLinked by 1 patent
  • Jonathan BeckwithResearcherExecutive OfficerLinked by $337K in grants as PI
  • Wesley J CookExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .